Sub Banner Image

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip

News

Rounak Jain

·

March 8, 2025

·

Benzinga

On Friday, Cathie Wood-led Ark Invest made some significant trades, with notable activity around stocks such as Roblox Corp. (NYSE:RBLX), Roku Inc. (NASDAQ:ROKU), UiPath Inc. (NYSE:PATH), Ibotta Inc. (NYSE:IBTA), Personalis Inc. (NGM: PSNL), Absci Corp. (NASDAQ:ABSI), and Recursion Pharmaceuticals Inc. (NASDAQ:RXRX).

The RBLX Trade

Ark Invest sold shares of Roblox Corp across multiple ETFs. The ARK Fintech Innovation ETF (NYSE:ARKF), ARK Innovation ETF (NYSE:ARKK), and ARK Next Generation Internet ETF (NYSE:ARKW) funds sold 1394, 1919, and 6558 shares respectively. This move came as Roblox’s stock closed at $57.17, down 2.39% on the day.

The total value of the sold shares, calculated from the latest closing price, amounts to approximately $568,000.

The ROKU Trade

Shares of Roku Inc were also sold across the ARKF, ARKK, and ARKW funds, totaling 3615, 6910, and 17704 shares respectively. Roku’s stock closed at $76.67, down 3.68% on the day.

The total value of the sold shares, calculated from the latest closing price, is approximately $2.3 million.

The PATH Trade

Shares of UiPath Inc were sold across the ARKK, ARK Autonomous Technology & Robotics ETF (BATS:ARKQ), and ARKW funds, totaling 237840, 11003, and 83559 shares respectively. UiPath’s stock closed at $12.31, up 4.77% on the day.

The total value of the sold shares, calculated from the latest closing price, is approximately $3.6 million.

The IBTA, PSNL, ABSI, and RXRX Trades

On the buying side, Ark Invest added shares of Ibotta Inc, Personalis Inc, Absci Corp, and Recursion Pharmaceuticals Inc to its ARKF and ARKG funds. The total value of these purchases, calculated from the latest closing prices, is approximately $2.8 million.

Read Next:

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo courtesy: Shutterstock

More from

Benzinga

More

News

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.